PICALM and Alzheimer’s Disease: An Update and Perspectives
Authors:
- Kunie AndoKAKunie Ando
- Siranjeevi NagarajSNSiranjeevi Nagaraj
- Fahri KüçükaliFKFahri Küçükali
- Marie-Ange de FisenneMFMarie-Ange de Fisenne
- Andreea-Claudia KosaAKAndreea-Claudia Kosa
- Emilie DoeraeneEmilie Doeraene
- Lidia Lopez GutierrezLidia Lopez Gutierrez
- Jean-Pierre BrionJBJean-Pierre Brion
- Karelle LeroyKLKarelle Leroy
Open Access
Abstract
Genome-wide association studies (GWAS) have identified the PICALM (Phosphatidylinositol binding clathrin-assembly protein) gene as the most significant genetic susceptibility locus after APOE and BIN1. PICALM is a clathrin-adaptor protein that plays a critical role in clathrin-mediated endocytosis and autophagy. Since the effects of genetic variants of PICALM as AD-susceptibility loci have been confirmed by independent genetic studies in several distinct cohorts, there has been a number of in vitro and in vivo studies attempting to elucidate the underlying mechanism by which PICALM modulates AD risk. While differential modulation of APP processing and Aβ transcytosis by PICALM has been reported, significant effects of PICALM modulation of tau pathology progression have also been evidenced in Alzheimer’s disease models. In this review, we summarize the current knowledge about PICALM, its physiological functions, genetic variants, post-translational modifications and relevance to AD pathogenesis.Keywords
Funding Information
- Belgian Fonds de la Recherche Scientifique Médicale (2019/0027)
- Fund Aline (King Baudouin Foundation) (14001)
- Foundation for Alzheimer Research (FRA/SAO) (2021/0028)
- Génicot Fund of ULB
This publication has 165 references indexed in Scilit:
- Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyMolecular Psychiatry, 2013
- Association of CLU and PICALM variants with Alzheimer's diseaseNeurobiology of Aging, 2012
- The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALMCell, 2011
- Genetic variations in the CLU and PICALM genes are associated with cognitive function in the oldest oldNeurobiology of Aging, 2011
- CR1 is associated with amyloid plaque burden and age‐related cognitive declineAnnals of Neurology, 2010
- Genetic Variation and Neuroimaging Measures in Alzheimer DiseaseArchives of Neurology, 2010
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate UptakeNeuron, 2009
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991